Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

STAT+: Justice Department targets drugmakers in new directive on combating white-collar fraud

The Justice Department issued a new directive for combating fraud that noted the agency will pursue violations of a federal law that tightly regulates the pharmaceutical industry.

STAT+: Justice Department targets drugmakers in new directive on combating white-collar fraud

The U.S. Department of Justice recently released a new directive aimed at combating fraud in the pharmaceutical industry, according to the National Fraud Enforcement Division. This directive explicitly includes the Federal Food, Drug, and Cosmetic Act, signaling a shift in the agency's focus towards drug and device manufacturers.

Historically, the agency has primarily pursued health fraud cases involving providers, clinics, home health agencies, and hospices. Kevin Lowell, a former deputy chief in the National Fraud Enforcement Division's health care fraud section, noted that this expansion of the DOJ's jurisdiction is subtle yet significant.

Rewritten by urgent.news; may contain errors — check the original.

Read the original at statnews.com →

Report a problem with this story

More in Health & Medicine

Public health intelligence - 2026

Public health intelligence - 2026 orlunwop@who.int Wed, 07/10/2026 - 13:08 The WHO African Region continued to face a complex and evolving landscape of public health threats in 2025, characterized by…

More from Wednesday 7 October →